Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 4
Out of 5,139 analysts
135
Total ratings
68.42%
Success rate
160.78%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $12.16 | -25.99% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $88.73 | +31.86% | 1 | Dec 1, 2025 | |
| DGX Quest Diagnostics | Maintains: Buy | $200 → $215 | $189.49 | +13.46% | 3 | Oct 21, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $387.37 | -0.61% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $139.64 | +11.00% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $108.08 | -25.98% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $33.20 | +32.53% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,460.63 | -24.69% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $235.99 | +10.17% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $270.87 | +7.06% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $12.79 | +72.01% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $74.98 | +13.36% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $47.57 | +11.35% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $41.41 | -15.48% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $112.50 | +11.11% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $20.52 | +16.96% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.21 | +81.00% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.00 | +50.00% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $231.25 | -38.59% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $112.14 | -71.46% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $141.65 | -18.81% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.92 | +237.84% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $618.72 | +5.06% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $19.18 | -53.08% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.18 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.89 | +534.92% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $7.40 | +710.81% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $5.45 | +322.02% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $219.70 | +77.51% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.69 | +569.14% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $535.00 | -62.62% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $25.24 | -4.91% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $12.21 | +268.55% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $162.02 | -56.80% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $237.68 | -49.51% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.84 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $48.39 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $10.50 | +423.81% | 1 | Jul 19, 2016 |
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $12.16
Upside: -25.99%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $88.73
Upside: +31.86%
Quest Diagnostics
Oct 21, 2025
Maintains: Buy
Price Target: $200 → $215
Current: $189.49
Upside: +13.46%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $387.37
Upside: -0.61%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $139.64
Upside: +11.00%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $108.08
Upside: -25.98%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $33.20
Upside: +32.53%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,460.63
Upside: -24.69%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $235.99
Upside: +10.17%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $270.87
Upside: +7.06%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $12.79
Upside: +72.01%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $74.98
Upside: +13.36%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $47.57
Upside: +11.35%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $41.41
Upside: -15.48%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $112.50
Upside: +11.11%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $20.52
Upside: +16.96%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $2.21
Upside: +81.00%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.00
Upside: +50.00%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $231.25
Upside: -38.59%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $112.14
Upside: -71.46%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $141.65
Upside: -18.81%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.92
Upside: +237.84%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $618.72
Upside: +5.06%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $19.18
Upside: -53.08%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.18
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.89
Upside: +534.92%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $7.40
Upside: +710.81%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $5.45
Upside: +322.02%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $219.70
Upside: +77.51%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.69
Upside: +569.14%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $535.00
Upside: -62.62%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $25.24
Upside: -4.91%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $12.21
Upside: +268.55%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $162.02
Upside: -56.80%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $237.68
Upside: -49.51%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.84
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $48.39
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $10.50
Upside: +423.81%